ALLYX THERAPEUTICS, INC.
Profile
Company Names
ALLYX THERAPEUTICS, INC.
Addresses
555 LONG WHARF DRIVE, FLOOR 11, NEW HAVEN, CT 06511
470 JAMES STREET, SUITE 007, NEW HAVEN, CT 06513
Phone Numbers
(908) 432-2845
2038550400
Entity Type:
CORPORATION
Industry:
BIOTECHNOLOGY
Year Incorporated:
2018
State Incorporated:
DELAWARE
Total Amount Raised:
$39,642,710.00
Number of Funding Rounds:
4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2026-05-04
$26,427,730.00
$29,999,999.00
$3,572,269.00
Equity
3
2026-02-23
$3,324,918.00
$4,000,000.00
$675,082.00
2
2023-02-03
$2,308,569.00
$2,308,569.00
$0.00
Equity
1
2021-05-26
$7,581,493.00
$8,031,491.00
$449,998.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
STEPHEN
BLOCH
EXECUTIVE OFFICER, DIRECTOR
VIACOR INC
| MARINUS PHARMACEUTICALS INC
| LIQUIDIA TECHNOLOGIES INC
| DICOM GRID INC
| AXIAL EXCHANGE, INC.
| ENVISIA THERAPEUTICS INC.
| LQ3 PHARMACEUTICALS, INC.
| ENVISIA THERAPEUTICS, INC.
| SAMPLE6, INC.
| GENOME MEDICAL HOLDING CO
| CORVIUM, INC.
| ONKOS SURGICAL, INC.
| EVOLVEIMMUNE THERAPEUTICS HOLDING COMPANY, LLC
| IANTREK, INC.
| LIQUIDIA CORP
| ALLYX THERAPEUTICS, INC.
| THYRON PHARMACEUTICALS, INC.
PAUL
FONTEYNE
DIRECTOR
GREGORY
P
HO
DIRECTOR
GREGORY
P.
HO
DIRECTOR
SMC HOLDINGS I, LP
| SMC HOLDINGS II, LP
| SMC HOLDINGS III, LP
| SMC ASSET ALLOCATION FUND, LP
| SMC PRIVATE EQUITY HOLDINGS, LP
| SMC ALPHA PLUS FUND, LP
| SMC TOTAL RETURN FUND, LP
| SMC PRIVATE CAPITAL FUND, LP
| ALLYX THERAPEUTICS, INC.
| WHIN OPPORTUNITY FUND, LP
| SMC PRIVATE CAPITAL FUND II, LP
| EPISTEME PROGNOSTICS, INC.
KEVIN
L.
RAKIN
DIRECTOR
STEPHEN
STRITTMATTER
EXECUTIVE OFFICER, DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
